Slingshot members are tracking this event:

FDA Approves Lannett's (LCI) Abbreviated New Drug Application for a Generic Version of Allergan's (AGN) Dementia Medication Namenda

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Abbreviated New Drug Application, Fda, Approval, Generic, Namenda, Dementia